首页> 外文期刊>Antiviral Research >Synthesis and antiviral activity of phosphoralaninate derivatives of methylenecyclopropane analogues of nucleosides.
【24h】

Synthesis and antiviral activity of phosphoralaninate derivatives of methylenecyclopropane analogues of nucleosides.

机译:核苷亚甲基环丙烷类似物的磷酸丙氨酸衍生物的合成及其抗病毒活性。

获取原文
获取原文并翻译 | 示例
       

摘要

Phenylmethylphosphoro-L-alaninate prodrugs of antiviral Z-methylenecyclopropane nucleoside analogues and their inactive E-isomers were synthesized and evaluated for their antiviral activity against HCMV, HSV-1, HSV-2, HHV-6, EBV, VZV, HIV-1 and HBV. The adenine Z-analogue was a potent inhibitor of all these viruses but it displayed cellular toxicity. The guanine Z-derivative was active against HCMV, HBV, EBV and VZV and it was not cytotoxic. The 2,6-diaminopurine analogue was the most potent against HIV-1 and HBV and somewhat less against HHV-6, HCMV, EBV and VZV in a non-cytotoxic concentration range. The 2-amino-6-cyclopropylamino and 2-amino-6-methoxypurine prodrugs were also more active than parent analogues against several viruses but with a less favorable cytotoxicity profile. In the E-series of analogues, adenine derivative was active against HIV-1, HBV and EBV, and it was non-cytotoxic. The guanine analogue exhibited a significant effect only against HBV. The 2,6-diaminopurine E-analogue was inactive with the exception of a single EBV assay. The 2-amino-6-methoxypurine Z-methylenecyclopropane nucleoside analogue was an effective inhibitor of HCMV, MCMV and EBV. The 2,6-diaminopurine Z-prodrug seems to be the best candidate for further development.
机译:合成了抗病毒Z-亚甲基环丙烷核苷类似物及其非活性E-异构体的苯甲基磷酸-L-丙氨酸盐前药,并评估了它们对HCMV,HSV-1,HSV-2,HHV-6,EBV,VZV,HIV-1和乙肝病毒。腺嘌呤Z-类似物是所有这些病毒的有效抑制剂,但显示出细胞毒性。鸟嘌呤Z衍生物对HCMV,HBV,EBV和VZV具有活性,并且无细胞毒性。在非细胞毒性浓度范围内,2,6-二氨基嘌呤类似物对HIV-1和HBV最有效,对HHV-6,HCMV,EBV和VZV的抵抗力较小。 2-氨基-6-环丙基氨基和2-氨基-6-甲氧基嘌呤的前药也比母体类似物对几种病毒更具活性,但细胞毒性却较差。在E系列类似物中,腺嘌呤衍生物对HIV-1,HBV和EBV具有活性,并且无细胞毒性。鸟嘌呤类似物仅对HBV显示出显著作用。除单个EBV测定外,2,6-二氨基嘌呤E-类似物无活性。 2-氨基-6-甲氧基嘌呤Z-亚甲基环丙烷核苷类似物是HCMV,MCMV和EBV的有效抑制剂。 2,6-二氨基嘌呤Z-前药似乎是进一步开发的最佳人选。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号